BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23187893)

  • 1. Effect of duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines.
    Eicher C; Dewerth A; Ellerkamp V; Fuchs J; Schott S; Armeanu-Ebinger S
    Pediatr Surg Int; 2013 Feb; 29(2):121-7. PubMed ID: 23187893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells.
    Schott S; Niessner H; Sinnberg T; Venturelli S; Berger A; Ikenberg K; Villanueva J; Meier F; Garbe C; Busch C
    Int J Cancer; 2012 Nov; 131(9):2165-74. PubMed ID: 22323315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof.
    Schott S; Wallwiener M; Kootz B; Seeger H; Fehm T; Neubauer H
    Invest New Drugs; 2011 Jun; 29(3):506-13. PubMed ID: 19997962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro activities of new anticancer duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) via a phosphodiester bonding.
    Schott H; Schott S; Schwendener RA
    Bioorg Med Chem; 2009 Oct; 17(19):6824-31. PubMed ID: 19744858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytostatic activity of the duplex drug linking 2'-deoxy-5-fluorouridine (5FdU) with 3'-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines.
    Weinreich J; Schott S; Königsrainer I; Zieker D; Königsrainer A; Schott H
    Invest New Drugs; 2011 Dec; 29(6):1294-302. PubMed ID: 20596746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis in cervical cancer cells by the duplex drug 5-FdU-ECyd, coupling 2'-deoxy-5-fluorouridine and 3'-C-ethinylcytidine.
    Schott S; Brüning A
    Gynecol Oncol; 2014 Nov; 135(2):342-8. PubMed ID: 25178996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells
    Schott S; Wimberger P; Klink B; Grützmann K; Puppe J; Wauer US; Klotz DM; Schröck E; Kuhlmann JD
    Oncotarget; 2017 Sep; 8(44):76935-76948. PubMed ID: 29100359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and antileukaemic activity of new duplexes linking 3-C-ethynylcytidine and 5-fluorodeoxyuridine.
    Novotny L; Rauko P; Schott H
    Anticancer Res; 2010 Dec; 30(12):4891-8. PubMed ID: 21187467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of gastric adenocarcinoma and normal cell lines against combined or conjugated antimetabolites.
    Weinreich J; Struller F; Küper M; Hack A; Königsrainer A; Schott TC
    Anticancer Drugs; 2013 Apr; 24(4):375-83. PubMed ID: 23358120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma.
    Lieber J; Eicher C; Wenz J; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
    BMC Cancer; 2011 Aug; 11():362. PubMed ID: 21854558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.
    Weinreich J; Struller F; Sautkin I; Giuashvili S; Reymond M; Königsrainer A; Schott TC
    Invest New Drugs; 2019 Jun; 37(3):415-423. PubMed ID: 30019100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a drug resistance model for hepatoblastoma.
    Eicher C; Dewerth A; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Int J Oncol; 2011 Feb; 38(2):447-54. PubMed ID: 21132272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145.
    Cattaneo-Pangrazzi RM; Schott H; Schwendener RA
    Prostate; 2000 Sep; 45(1):8-18. PubMed ID: 10960838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
    Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased efficacy of CDDP in a xenograft model of hepatoblastoma using the apoptosis sensitizer ABT-737.
    Lieber J; Dewerth A; Wenz J; Kirchner B; Eicher C; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Oncol Rep; 2013 Feb; 29(2):646-52. PubMed ID: 23229825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts.
    Eicher C; Dewerth A; Thomale J; Ellerkamp V; Hildenbrand S; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Br J Cancer; 2013 Feb; 108(2):334-41. PubMed ID: 23257893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer activities of amphiphilic 5-fluoro-2'-deoxyuridylic acid prodrugs.
    Ludwig PS; Schwendener RA; Schott H
    Eur J Med Chem; 2005 May; 40(5):494-504. PubMed ID: 15893023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of beta-catenin in hepatoblastoma cells.
    Ellerkamp V; Lieber J; Nagel C; Wenz J; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Pediatr Surg Int; 2013 Feb; 29(2):141-9. PubMed ID: 23266718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
    Seitz G; Krause R; Fuchs J; Heitmann H; Armeanu S; Ruck P; Warmann SW
    Oncol Rep; 2008 Nov; 20(5):1277-82. PubMed ID: 18949433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.